Legend Biotech (Legend Biotech) Other Stockholders Equity : $66.3 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Other Stockholders Equity?

Legend Biotech's Other Stockholders Equity for the quarter that ended in Mar. 2024 was $66.3 Mil.

Legend Biotech's quarterly Other Stockholders Equity increased from Sep. 2023 ($44.6 Mil) to Dec. 2023 ($54.6 Mil) and increased from Dec. 2023 ($54.6 Mil) to Mar. 2024 ($66.3 Mil).

Legend Biotech's annual Other Stockholders Equity increased from Dec. 2021 ($19.7 Mil) to Dec. 2022 ($39.0 Mil) and increased from Dec. 2022 ($39.0 Mil) to Dec. 2023 ($54.6 Mil).

Legend Biotech Other Stockholders Equity Historical Data

The historical data trend for Legend Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Other Stockholders Equity Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

1.98

6.31

19.70

39.05

54.62

Legend Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	44.61	54.62	66.35

Legend Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Legend Biotech Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Legend Biotech's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech (Legend Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

9LB:Germany

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.